Adiponectin and lipid profiles compared with insulins in relation to early growth of British South Asian and European children: the Manchester children's growth and vascular health study.

CONTEXT Adiponectin, high-density lipoprotein cholesterol (HDL-C) and insulin concentrations may be important in the pathophysiology of cardiovascular disease. OBJECTIVE We tested the hypothesis that serum adiponectin rather than insulin differs from early life, between South Asians and Europeans, with a potentially key role in excess cardiovascular risk characteristic of adult South Asians. DESIGN AND PARTICIPANTS We conducted a longitudinal study of 215 British-born children of European (n = 138) and South Asian (n = 77) origin, from birth to 3 yr. MAIN OUTCOME MEASURE Serum adiponectin, insulin, proinsulin and HDL-C concentrations were assessed in relation to ethnic group and growth in anthropometric variables from 0-3 yr of age. RESULTS Serum adiponectin was lower in South Asian children, despite their smaller size, notable at age 3-6 months (9.5 vs. 11.8 mg/liter; P = 0.04), with no ethnic differences in serum lipids or insulin or proinsulin. In mixed-effects longitudinal models for HDL-C, determinants were adiponectin (P = 0.034), age (P < 0.001), and body mass index (P < 0.001) but not ethnicity. None of these or growth variables affected either insulin or proinsulin. In a fully adjusted mixed-effects longitudinal model including age, sex, insulin, and proinsulin, the independent determinants of serum adiponectin were height [21.3 (95% confidence interval = 31.7-10.8 cm lower, for every 1 mmol/liter increase in adiponectin, P < 0.001], HDL-C [2.8 (1.3-4.2) mmol/liter higher, P < 0.0001], body mass index (lower, P = 0.03), and South Asian ethnicity (lower, P = 0.01). CONCLUSIONS These British South Asian-origin infants have lower serum adiponectin but no differences in HDL-C or insulin molecules. In South Asians, factors affecting adiponectin metabolism in early life, rather than insulin resistance, likely determine later excess cardiovascular risk.

[1]  B. Zinman,et al.  Hypoadiponectinaemia in South Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[2]  S. Kihara,et al.  Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin , 2004, Circulation research.

[3]  J. Medalie,et al.  Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[4]  C. Lamendola,et al.  Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. , 2007, Metabolism: clinical and experimental.

[5]  G. Lewis.  Determinants of plasma HDL concentrations and reverse cholesterol transport , 2006, Current opinion in cardiology.

[6]  S. Grundy,et al.  Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. , 2004, The Journal of clinical endocrinology and metabolism.

[7]  W. Garvey,et al.  Adiponectin multimeric complexes and the metabolic syndrome trait cluster. , 2006, Diabetes.

[8]  C. Bogardus,et al.  Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. , 2002, Diabetes.

[9]  Jonathan Krakoff,et al.  Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.

[10]  P. Gambert,et al.  Adiponectin Is an Important Determinant of ApoA-I Catabolism , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[11]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.

[12]  P. McElduff,et al.  Adiponectin in umbilical cord blood is inversely related to low-density lipoprotein cholesterol but not ethnicity. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.

[14]  A. Goldfine,et al.  Adiponectin: linking the fat cell to insulin sensitivity , 2003, The Lancet.

[15]  B. Zinman,et al.  Low Serum Levels of High–Molecular Weight Adiponectin in Indo-Asian Women During Pregnancy , 2006, Diabetes Care.

[16]  E. Sivan,et al.  Adiponectin in human cord blood: relation to fetal birth weight and gender. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  E. Rimm,et al.  Leisure-time physical activity, television watching, and plasma biomarkers of obesity and cardiovascular disease risk. , 2000, American journal of epidemiology.

[18]  P. Havel.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin , 2002, Current opinion in lipidology.

[19]  F. Hu,et al.  The metabolic syndrome as a cluster of risk factors: is the whole greater than the sum of its parts?: comment on "The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis". , 2010, Archives of internal medicine.

[20]  N. Ruderman,et al.  Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists* , 2006, Journal of Biological Chemistry.

[21]  H. Lebovitz,et al.  Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. , 1999, The Journal of clinical endocrinology and metabolism.

[22]  U. Müller-Ladner,et al.  Adiponectin represents an independent cardiovascular risk factor predicting serum HDL‐cholesterol levels in type 2 diabetes , 2003, FEBS letters.

[23]  S. Grundy,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Relationship between Generalized and Upper Body Obesity to Insulin Resistance in Asian Indian Men* , 2022 .

[24]  E. Ding,et al.  Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. , 2009, JAMA.

[25]  C. Yajnik,et al.  Neonatal anthropometry: the thin–fat Indian baby. The Pune Maternal Nutrition Study , 2003, International Journal of Obesity.

[26]  G. Lewis,et al.  Lipolytically Modified Triglyceride-Enriched HDLs Are Rapidly Cleared From the Circulation , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[27]  J. Després,et al.  Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  J. Cruickshank,et al.  Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure , 1991, The Lancet.

[29]  J S Yudkin,et al.  Adiposity and hyperinsulinemia in Indians are present at birth. , 2002, The Journal of clinical endocrinology and metabolism.

[30]  S. Bentley.  Heat attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites. , 1980, British medical journal.

[31]  M. Marmot,et al.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians , 1991, The Lancet.

[32]  J. Schneider,et al.  Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. , 2005, Diabetes care.

[33]  R. Vigneri,et al.  Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. , 2004, The Journal of clinical endocrinology and metabolism.

[34]  N. Al-Daghri,et al.  Fasting serum adiponectin concentration is reduced in Indo‐Asian subjects and is related to HDL cholesterol , 2003, Diabetes, obesity & metabolism.

[35]  S. Haffner,et al.  Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. , 2003, Diabetes care.

[36]  D. Cook,et al.  Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children , 2002, BMJ : British Medical Journal.

[37]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[38]  S. Yusuf,et al.  Carbohydrate intake and HDL in a multiethnic population. , 2007, The American journal of clinical nutrition.

[39]  D. Beevers,et al.  Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England. , 1980, British medical journal.

[40]  M. Rosato,et al.  Trends for coronary heart disease and stroke mortality among migrants in England and Wales, 1979–2003: slow declines notable for some groups , 2007, Heart.

[41]  D. Sellu,et al.  The Southall diabetes survey: prevalence of known diabetes in Asians and Europeans. , 1985, British medical journal.

[42]  B. Zinman,et al.  Adiponectin in a native Canadian population experiencing rapid epidemiological transition. , 2003, Diabetes care.

[43]  Paul Schoenhagen,et al.  The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. , 2010, Archives of internal medicine.

[44]  John A Wagner,et al.  Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.